Table 3.
Series of Sleeve Gastrectomy studies with at least 10-year FU
| Author, year | Number of patients | Study design | Mean EWL (SD) | T2D resolution | HTN resolution | De-novo GERD | Revisional surgery during FU |
|---|---|---|---|---|---|---|---|
| Felsenreich, 2016 [15] | 53 | Retrospective | 53.5% (26.6) | 1.9%** | 23.5%** | N/A | 36% |
| Castagneto Gissey, 2018 [16] | 114 | Retrospective | 52.5% (21.1) | 64.7% | 44.2% | 42.9% | 44% |
| Hauters, 2021 [18] | 34 | Retrospective | 42% (37) | 12% | 17% | 41% | 18% |
| Musella, 2019 [19] | 76 | Retrospective | 50.1% (30.5) | 0% | 51.4% | 25.7% | 15.8% |
| Kraljević, 2021 [20] | 215 | Retrospective | 53.6% (24.6)* | 61% | 60.5% | 32.4% | 19.2% |
| Chang, 2018 [21] | 65 | Retrospective | 70.5% (27.8) | 39.6% | 78.4% | 58.4% | 21.5% |
| Arman, 2016 [24] | 65 | Retrospective | 67.4% | N/A | 28.6%** | 21.4% | 31.7% |
FU, follow-up; T2D, type 2 diabetes; HTN, hypertension; EWL, excess weight loss; GERD, gastroesophageal reflux disease; N/A, not available
*Corresponds to primary sleeve gastrectomy only
**Includes patients with resolution and/or improvement of T2D/HTN